Overview

A Study Evaluating Megestrol Acetate Modulation in Hormone Receptor Positive Advanced Breast Cancer

Status:
Unknown status
Trial end date:
2020-09-01
Target enrollment:
Participant gender:
Summary
This pilot trial evaluates in vivo megestrol acetate (MA) modulation of steroidal receptors in advanced breast cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Instituto Nacional de Cancer, Brazil
Collaborator:
Cancer Research UK Cambridge Institute
Treatments:
Anastrozole
Exemestane
Fulvestrant
Letrozole
Megestrol
Megestrol Acetate
Tamoxifen